Top compounds associated with response to TICRR


Feature Type Standardized
Nominal ANOVA
mRNA Doxorubicin CTRPv2 pan-cancer AAC 0.14 4e-06
mRNA KX2-391 CTRPv2 pan-cancer AAC 0.15 4e-06
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.15 5e-06
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 5e-06
mRNA GSK1070916 GDSC1000 pan-cancer AAC 0.15 5e-06
mRNA SB-743921 CTRPv2 pan-cancer AAC 0.15 6e-06
mRNA decitabine CTRPv2 pan-cancer AAC 0.13 7e-06
mRNA vincristine CTRPv2 pan-cancer AAC 0.14 8e-06
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 1e-05
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.14 1e-05
Download CSV